ZHZhenzhen Han

Zhenzhen Han

*This is an algorithmically generated author record based on publicly available information.

Zhenzhen Han has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Hongtao Guo

    The First Affiliated Hospital of Henan University of Chinese Medicine,Henan,China

    2 shared publications
  • Feng Qi

    Department of General Surgery, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China; Tianjin Key Laboratory of Precise Vascular Reconstruction and Organ Function Repair, 154 Anshan Road, Heping District, Tianjin 300052, China

    1 shared publication
  • Guang Zheng

    International Institute for Earth System Science, Nanjing University, Nanjing 210023, China

    1 shared publication
  • Haowen Jia

    Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China

    1 shared publication
  • Hongwen Huang

    Department of Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China School of Basic

    1 shared publication
  • Jinlong Yu

    Department of General Surgery, Zhujiang Hospital Southern Medical University Guangzhou Guangdong China

    1 shared publication

Latest Publications

  • AP-1 Network Shared in Pathways of Rheumatoid Arthritis Subtyped Liver-kidney Deficiency Characterize the Pathology

    by Guang Zheng, Ye Lv, Zhenzhen Han, Hongtao Guo

    Differentially expressed genes (DEGs) shared among different yet associated pathways on rheumatoid arthritis (RA) may shed light on its pathology study. In this study, DEGs of RA subtyped liver-kidney deficiency (a syndrome in traditional Chinese medicine) were collected from the GSE205962 dataset toward the roles they played among RA-associated pathways. GWAS (genome-wide association study) and enrichment analysis demonstrated that the AP-1 transcription factor-associated genes are the top DEGs shared by the RA-associated pathways. As a result, the AP-1 delivers complex regulations on immune responses e.g. activating T cells via up-regulating JUN, FOS, MAPKs, and NFKB1B while inhibiting IKBKB, LCK, NFKB1, CD3D, et al. The protein networks of DEGs shared in the T cell receptor signaling pathway and Th17 cell differentiation, together with the AP-1-centered network, were proposed.

  • Analysis of the effect of the interaction between medical and comorbidities on hospital readmission in patients with rheumatoid arthritis based on case data

    by Lifeng Fa, Kuo Yang, Jinlong Yu, Ning Xu, Zhenzhen Han, Hongtao Guo, Lei Zhang

    This study utilized electronic medical record data of RA inpatients to ascertain potential risk factors associated with patient readmission. Specifically, the investigation concentrated on the impact of various Traditional Chinese Medicine (TCM) syndromes, comorbidities, interactions between TCM syndromes and comorbidities, as well as interactions among comorbidities themselves, on the likelihood of hospital readmission among RA patients. The present study employed logistic regression analysis to examine the interaction between dichotomous variables. The findings revealed that individuals diagnosed with rheumatoid arthritis (RA) and experiencing arthralgia caused by wind-cold-dampness, in addition to hyperlipidemia, exhibited a heightened likelihood of hospital readmission. Similarly, RA patients with hyperlipidemia and the syndrome of dampness-heat blocking collaterals were found to be at an even greater risk of readmission. Furthermore, individuals with RA and comorbidities such as atherosclerosis and chronic gastritis were identified as being at a high risk of readmission. Lastly, RA patients with hyperlipidemia and fatty liver were also found to have an increased likelihood of being readmitted to the hospital. Hence, it is advisable to closely monitor the disease progression among the aforementioned population and implement essential interventions in clinical practice to mitigate the readmission rate of patients with rheumatoid arthritis (RA), consequently alleviating the disease and economic burdens experienced by patients.


  • Open Access

    The ethics of COVID-19 clinical trials: New considerations in a controversial area

    by Zhenzhen Han, Junting Wang, Kai Zhang, Qilin Tang


  • Open Access

    Acupuncture and related interventions for anxiety in coronavirus disease 2019

    by Haowen Jia, Zhenzhen Han, Kai Zhang, Qilin Tang, Kaihang Sun, Hongwen Huang, Feng Qi

    Background: Traditional Chinese medicine plays an irreplaceable role in the treatment and prevention of epidemic diseases in China. Acupuncture is an important part of Chinese medicine. During the coronavirus disease 2019 (COVID-19) epidemic, acupuncture and related interventions are used to treat COVID-19 patients in China. The systematic review aims to evaluate the efficacy and safety of acupuncture and relevant interventions for anxiety in COVID-19. Methods: We will search for randomized control and observational studies of acupuncture and related interventions for anxiety in COVID-19 in the 6 databases from inception to 31 October 2020. There is no language restriction. Two independent reviewers will screen and collect all trials, data extraction and evaluate the risk of bias of the researches. We will perform a meta-analysis if appropriate. Results: Our findings will evaluate the feasibility of acupuncture and related interventions as adjunctive therapy for anxiety in COVID-19 patients, which will be disseminated in a relevant conference and published in a peer-reviewed publication. Conclusion: Our research will appraise the overall quality and evidence of whether acupuncture and related interventions are effective therapies for anxiety in COVID-19.